Jump to content

Details of the Gilead trial are purely anecdotal


veeraveeraleaks

Recommended Posts

While infectious disease experts caution against jumping to conclusions, saying the new details of the Gilead trial are purely anecdotal, retail investors are “hungry” for good news on the virus, analysts say

 

 

 

 

https://www.cnbc.com/2020/04/17/biotech-stocks-surge-as-people-are-hungry-for-good-news-on-coronavirus.html

Link to comment
Share on other sites

Remdesivir has shown some promise in treating SARS and MERS, which are also caused by coronaviruses. Some health authorities in the U.S., China and other parts of the world have also been using remdesivir, which was tested as a possible treatment for the Ebola outbreak, in hopes that the drug can reduce the duration of Covid-19 in patients.

Former Food and Drug Administration Commissioner Scott Gottlieb said while the new details from the Gilead trial are hopeful, they are “not a slam dunk.”

“If it does work, I don’t think this is a cure,” he said Friday during an interview with CNBC’s “Squawk Box.” “I don’t think this is going to be the one drug answer to this disease, but it can change the contours of the disease and mitigate the worst outcomes for some patients.”

Link to comment
Share on other sites

3 minutes ago, JambaKrantu said:

A drug that can cure the severe cases is wonderful news bro..

Chicago lo 100 people meedha work out ayyinantha mathrana across the globe on different ages meedha efficacy untadha?

We cant get carried away by such a small sample. Furthermore, the credibility of professor is at stake since Gilead is not supporting the claims if they are so positive.

But anyways, its a good sign but still long way to go

Link to comment
Share on other sites

7 minutes ago, JambaKrantu said:

Remdesivir has shown some promise in treating SARS and MERS, which are also caused by coronaviruses. Some health authorities in the U.S., China and other parts of the world have also been using remdesivir, which was tested as a possible treatment for the Ebola outbreak, in hopes that the drug can reduce the duration of Covid-19 in patients.

Former Food and Drug Administration Commissioner Scott Gottlieb said while the new details from the Gilead trial are hopeful, they are “not a slam dunk.”

“If it does work, I don’t think this is a cure,” he said Friday during an interview with CNBC’s “Squawk Box.” “I don’t think this is going to be the one drug answer to this disease, but it can change the contours of the disease and mitigate the worst outcomes for some patients.”

If it's already there what's so new about finding it now?

Link to comment
Share on other sites

2 minutes ago, veeraveeraleaks said:

Chicago lo 100 people meedha work out ayyinantha mathrana across the globe on different ages meedha efficacy untadha?

We cant get carried away by such a small sample. Furthermore, the credibility of professor is at stake since Gilead is not supporting the claims if they are so positive.

But anyways, its a good sign but still long way to go

Trails anevi all age test cases meedha chestharu emo ga, not confined to certain age group..!

Link to comment
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

×
×
  • Create New...